⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine EU July 9, 2024

Zypadhera

📷 Wikipedia: Olanzapine · Source
Zypadhera
📷 Wikipedia: Olanzapine · Source
INN
olanzapine
Forms
Powder and solvent for prolonged-release suspension for injection
Strengths
210 mg;300 mg;405 mg
Area
Schizophrenia
Alternatives
Yes
⚠️
Shortage ongoing
olanzapine is currently in short supply in EU.
📈 Timeline
119 days active so far
May 16, 2026 September 11, 2026

What is this? Zypadhera is a medicine used for schizophrenia. It comes as a shot that lasts a long time.

What's happening? There is a shortage of Zypadhera in the EU. Supplies are low right now.

Does this affect me? If you take Zypadhera, you may be affected. Ask your doctor or pharmacist about other options.

What should I do? Do not stop taking your medicine without advice. Talk to your pharmacist or doctor about alternatives.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
olanzapine
Brand(s) / product name(s)
Zypadhera
Agency-published detail

INN: olanzapine · Forms: Powder and solvent for prolonged-release suspension for injection · Strengths: 210 mg;300 mg;405 mg · Area: Schizophrenia · Alternatives: Yes

First published
July 9, 2024
Last refreshed by us
10 hours ago
Severity (as classified)
High
Official source
https://www.ema.europa.eu/en/medicines/human/shortages/zypadhera

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Zypadhera. INN: olanzapine · Forms: Powder and solvent for prolonged-release suspension for injection · Strengths: 210 mg;300 mg;405 mg · Area: Schizophrenia · Alternatives: Yes
▸ When was this alert issued?
This alert was issued on July 9, 2024 by EMA (European Medicines Agency).
▸ Which countries are affected?
The alert applies to the entire EU.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on www.ema.europa.eu.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.